BAXTER INTERNATIONAL INC (1BAX.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1BAX • US0718131099

30.905 EUR
+0.18 (+0.57%)
Last: Mar 26, 2025, 07:00 PM
Fundamental Rating

3

Overall 1BAX gets a fundamental rating of 3 out of 10. We evaluated 1BAX against 63 industry peers in the Health Care Equipment & Supplies industry. 1BAX has a bad profitability rating. Also its financial health evaluation is rather negative. 1BAX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • 1BAX had positive earnings in the past year.
  • 1BAX had a positive operating cash flow in the past year.
  • In multiple years 1BAX reported negative net income over the last 5 years.
  • In the past 5 years 1BAX always reported a positive cash flow from operatings.
1BAX.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

  • 1BAX has a Return On Assets (-2.52%) which is comparable to the rest of the industry.
  • 1BAX has a Return On Equity of -9.32%. This is comparable to the rest of the industry: 1BAX outperforms 40.35% of its industry peers.
  • 1BAX's Return On Invested Capital of 3.45% is in line compared to the rest of the industry. 1BAX outperforms 49.12% of its industry peers.
  • 1BAX had an Average Return On Invested Capital over the past 3 years of 3.20%. This is significantly below the industry average of 9.98%.
  • The last Return On Invested Capital (3.45%) for 1BAX is above the 3 year average (3.20%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.52%
ROE -9.32%
ROIC 3.45%
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
1BAX.MI Yearly ROA, ROE, ROIC1BAX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • With a Operating Margin value of 7.67%, 1BAX perfoms like the industry average, outperforming 56.14% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1BAX has declined.
  • 1BAX has a Gross Margin of 38.01%. This is in the lower half of the industry: 1BAX underperforms 71.93% of its industry peers.
  • 1BAX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.67%
PM (TTM) N/A
GM 38.01%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
1BAX.MI Yearly Profit, Operating, Gross Margins1BAX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

  • 1BAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for 1BAX has been increased compared to 1 year ago.
  • 1BAX has more shares outstanding than it did 5 years ago.
  • 1BAX has a worse debt/assets ratio than last year.
1BAX.MI Yearly Shares Outstanding1BAX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1BAX.MI Yearly Total Debt VS Total Assets1BAX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • 1BAX has an Altman-Z score of 2.10. This is not the best score and indicates that 1BAX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1BAX has a Altman-Z score (2.10) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of 1BAX is 22.91, which is on the high side as it means it would take 1BAX, 22.91 years of fcf income to pay off all of its debts.
  • 1BAX has a Debt to FCF ratio of 22.91. This is comparable to the rest of the industry: 1BAX outperforms 50.88% of its industry peers.
  • A Debt/Equity ratio of 1.79 is on the high side and indicates that 1BAX has dependencies on debt financing.
  • 1BAX has a worse Debt to Equity ratio (1.79) than 82.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF 22.91
Altman-Z 2.1
ROIC/WACC0.53
WACC6.49%
1BAX.MI Yearly LT Debt VS Equity VS FCF1BAX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • 1BAX has a Current Ratio of 1.36. This is a normal value and indicates that 1BAX is financially healthy and should not expect problems in meeting its short term obligations.
  • 1BAX has a Current ratio (1.36) which is comparable to the rest of the industry.
  • 1BAX has a Quick Ratio of 1.05. This is a normal value and indicates that 1BAX is financially healthy and should not expect problems in meeting its short term obligations.
  • 1BAX has a Quick ratio of 1.05. This is comparable to the rest of the industry: 1BAX outperforms 50.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.05
1BAX.MI Yearly Current Assets VS Current Liabilites1BAX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.37% over the past year.
  • 1BAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.21% yearly.
  • The Revenue for 1BAX has decreased by -13.21% in the past year. This is quite bad
  • Measured over the past years, 1BAX shows a decrease in Revenue. The Revenue has been decreasing by -1.31% on average per year.
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.87% on average over the next years.
  • Based on estimates for the next years, 1BAX will show a small growth in Revenue. The Revenue will grow by 5.61% on average per year.
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1BAX.MI Yearly Revenue VS Estimates1BAX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
1BAX.MI Yearly EPS VS Estimates1BAX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

  • 1BAX is valuated correctly with a Price/Earnings ratio of 12.61.
  • Based on the Price/Earnings ratio, 1BAX is valued cheaply inside the industry as 89.47% of the companies are valued more expensively.
  • 1BAX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.93.
  • With a Price/Forward Earnings ratio of 13.58, 1BAX is valued correctly.
  • 75.44% of the companies in the same industry are more expensive than 1BAX, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of 1BAX to the average of the S&P500 Index (27.77), we can say 1BAX is valued rather cheaply.
Industry RankSector Rank
PE 12.61
Fwd PE 13.58
1BAX.MI Price Earnings VS Forward Price Earnings1BAX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1BAX indicates a somewhat cheap valuation: 1BAX is cheaper than 78.95% of the companies listed in the same industry.
  • 1BAX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1BAX is cheaper than 73.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.59
EV/EBITDA 13.5
1BAX.MI Per share data1BAX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y3.75%

4

5. Dividend

5.1 Amount

  • 1BAX has a Yearly Dividend Yield of 2.17%. Purely for dividend investing, there may be better candidates out there.
  • 1BAX's Dividend Yield is rather good when compared to the industry average which is at 0.97. 1BAX pays more dividend than 80.70% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, 1BAX pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

  • The dividend of 1BAX is nicely growing with an annual growth rate of 6.89%!
Dividend Growth(5Y)6.89%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • The earnings of 1BAX are negative and hence is the payout ratio. 1BAX will probably not be able to sustain this dividend level.
  • 1BAX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-90.91%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
1BAX.MI Yearly Income VS Free CF VS Dividend1BAX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

BAXTER INTERNATIONAL INC

BIT:1BAX (3/26/2025, 7:00:00 PM)

30.905

+0.18 (+0.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-20
Earnings (Next)04-24
Inst Owners97.07%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap15.85B
Revenue(TTM)12.86B
Net Income(TTM)-649.00M
Analysts68.18
Price Target35.44 (14.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend1.05
Dividend Growth(5Y)6.89%
DP-90.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.32%
Min EPS beat(2)1.94%
Max EPS beat(2)10.69%
EPS beat(4)4
Avg EPS beat(4)5.06%
Min EPS beat(4)1.64%
Max EPS beat(4)10.69%
EPS beat(8)7
Avg EPS beat(8)3.73%
EPS beat(12)8
Avg EPS beat(12)2.99%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)1.93%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.54%
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)-31.48%
EPS NQ rev (3m)-31.48%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-22.05%
Revenue NQ rev (1m)-30.35%
Revenue NQ rev (3m)-30.35%
Revenue NY rev (1m)-28.82%
Revenue NY rev (3m)-28.82%
Valuation
Industry RankSector Rank
PE 12.61
Fwd PE 13.58
P/S 1.36
P/FCF 30.59
P/OCF 17.2
P/B 2.52
P/tB N/A
EV/EBITDA 13.5
EPS(TTM)2.45
EY7.93%
EPS(NY)2.28
Fwd EY7.36%
FCF(TTM)1.01
FCFY3.27%
OCF(TTM)1.8
OCFY5.81%
SpS22.67
BVpS12.28
TBVpS-6.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.52%
ROE -9.32%
ROCE 5.12%
ROIC 3.45%
ROICexc 3.76%
ROICexgc 8.07%
OM 7.67%
PM (TTM) N/A
GM 38.01%
FCFM 4.46%
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
ROICexc(3y)3.57%
ROICexc(5y)5.33%
ROICexgc(3y)9.57%
ROICexgc(5y)12.38%
ROCE(3y)4.43%
ROCE(5y)6.16%
ROICexgc growth 3Y-30.34%
ROICexgc growth 5Y-21.96%
ROICexc growth 3Y-22.52%
ROICexc growth 5Y-26.32%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
F-Score3
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF 22.91
Debt/EBITDA 6.3
Cap/Depr 44.73%
Cap/Sales 3.47%
Interest Coverage 4.42
Cash Conversion 51.39%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.05
Altman-Z 2.1
F-Score3
WACC6.49%
ROIC/WACC0.53
Cap/Depr(3y)49.31%
Cap/Depr(5y)63.51%
Cap/Sales(3y)5.12%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
EBIT growth 1Y-21.12%
EBIT growth 3Y-30.01%
EBIT growth 5Y-18.5%
EBIT Next Year69.69%
EBIT Next 3Y22.35%
EBIT Next 5Y25.92%
FCF growth 1Y-44.58%
FCF growth 3Y-27.1%
FCF growth 5Y-16.46%
OCF growth 1Y-40.96%
OCF growth 3Y-22.88%
OCF growth 5Y-13.5%

BAXTER INTERNATIONAL INC / 1BAX.MI FAQ

What is the ChartMill fundamental rating of BAXTER INTERNATIONAL INC (1BAX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1BAX.MI.


Can you provide the valuation status for BAXTER INTERNATIONAL INC?

ChartMill assigns a valuation rating of 5 / 10 to BAXTER INTERNATIONAL INC (1BAX.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for BAXTER INTERNATIONAL INC?

BAXTER INTERNATIONAL INC (1BAX.MI) has a profitability rating of 3 / 10.


What is the valuation of BAXTER INTERNATIONAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BAXTER INTERNATIONAL INC (1BAX.MI) is 12.61 and the Price/Book (PB) ratio is 2.52.


Can you provide the dividend sustainability for 1BAX stock?

The dividend rating of BAXTER INTERNATIONAL INC (1BAX.MI) is 4 / 10 and the dividend payout ratio is -90.91%.